EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
From Listening to Leading: Reimagining HEOR Through the Lens of Patient-Centred Evidence
Co-Founder & Director, MarksMan Healthcare
Dimple Dang CoFounder of MarksMan Healthcare is a strategic growth architect shaping the firms global footprint She forges highimpact collaborations leads business expansion and builds a talent ecosystem aligned with excellence Her leadership elevates credibility strengthens brand equity and positions MarksMan as a trusted strategic partner delivering value across global healthcare markets
Articles
Unlocking New Avenues in Cancer Therapy by Targeting Ubiquitin-Specific Proteases
The ubiquitinproteasome system UPS is a crucial mechanism that helps maintain balance within our cells by breaking down damaged or excess proteins Central to this process is ubiquitination where a small protein called ubiquitin made up of amino acids attaches to target proteins thus influencing the proteins stability location within the cell and its ability to interact with other molecules
Research Insights
Critical parameters in targeted drug development: the pharmacological audit trail
Abstract The Pharmacological Audit Trail PhAT comprises a set of critical questions that need to be asked during discovery and development of an anticancer drug Key aspects include defining a patient population establishing pharmacokinetic characteristics providing evidence of target engagement pathway modulation and biological effect with proof
Case Studies
Impact Of Substitution Among Generic Drugs On Persistence And Adherence:a Retrospective Claims Data Case Study
Abstract Once the period of exclusivity on a reference medicine expires it is possible to apply for marketing of a generic version of that medicine By definition a generic product is considered interchangeable with the innovator brand product when it demonstrates the same qualitative and quantitative composition in active substances the same pharmaceutical form and bi...
Techno Trends
China's New Regulations to Enhance Efficiency in Drug Manufacturing
New regulatory changes in China aim to boost the efficiency of drug manufacturing processes
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Syringe-like Bacterial Nanomachine Emerges as Potential Therapeutics Delivery Device
I am Chanchal Kumawat. I started my journey in science as Ph.D. student at Regional Centre for Biotechnology and continued as postdoctoral fellow at Max Perutz labs, Austria. I enjoyed making scientific discoveries in the laboratory and now, enjoy communicating it as a science writer.
Lipid Excipients and Formulation Development
Apoorva More works as Assistant Professor in Pharmaceutical Chemistry department at St. John Institute of Pharmacy and Research, Palghar. She has completed her M. Pharm in Quality Assurance. Her research interests are Lipid based technologies, formulation development, nutraceuticals and novel drug delivery systems.
Bharat Dhokchawale is currently working at St. John Institute of Pharmacy and Research as Associate Professor and Head of Pharmaceutical Chemistry department. He holds Ph. D. in Pharmaceutical Sciences. His research interest includes Prodrug synthesis, synthetic chemistry and solubility enhancement of poorly water soluble drugs. He has total 14 years of teaching experience and 19 publications to his credit in International and National journals of repute. He has presented several papers in international conferences.
The Unknown Sources of Error in the Pharmaceutical Weighing Process
Thomas Caratsch has been the Head of Laboratory Division since December 2007 at the company's headquarters in Greifensee, Switzerland. Prior to joining the company, Caratsch held various management positions within the Hoffmann La Roche group in the U.S. and Switzerland, including General Manager of Roche Instrument Centre AG and Head of Disetronic Medical Systems AG. He began his career as a development engineer at Sodeco-Saia in Geneva.
Why tier-2 and tier-3 cities are not included for clinical research
Co-Founder at DPHS Pvt. Ltd., Dr. Krutikesh Age is a researcher and a visionary committed towards propelling the field of clinical research and healthcare expansion in India. As the Co-founder of DPHS, Krutikesh manages varied key roles including Leadership, developing business and marketing strategies and Networking to name a few. It is through the deep understanding of clinical research and market dynamics that he has been instrumental in expanding the operations of DPHS in the past few years.
Impact Assessment of US Tariff Threat on Indian Healthcare Export
Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry and academic accomplishments. During his industry stay he became a seasoned scientist and dealt with challenging NCE/NDA development. He is on advisory boards of some international research-based companies of India, New Zealand and Europe. Academics and Research being close to his heart, he has published more than 110 manuscripts in the journals of international repute and has been granted 02 Indian patent and filed for 04. He has contributed several chapters in books published by reputed authors like Elsevier and Bentham. He is amongst the very few scientists globally who has an expertise in Humic substances research. A well-travelled scientist; he has delivered scientific addresses in countries like USA, Austria, Japan, Netherlands, Turkey, Estonia, Spain and Russia. He has been Elite Fellow at University of Malaya (Malaysia) for the last 5 years where he takes classes on the topics related to industrial pharmacy.
press releasesRead more...
Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.
Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs
Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform
Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership
Zymeworks Completes Acquisition of Theravance Biopharma
Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed
UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases
Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong
Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services
Oracle Life Sciences announced a partnership with Wipro Limited a leading AIpowered technology services and consulting company to strengthen Wipros pharmacovigilance PV service offering using Oracle Life
EventsRead more...
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
01 - 01
Oct 2026Articulate 2026: The Communication Revolution
Philadelphia, United States
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
LATEST NEWSRead more...
Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration
Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling
TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation
TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures
SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy
SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA
Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration
Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration
Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases
Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases
Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease
Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD